Press Releases OncoCyte Corporation

Equities

OCX

US68235C2061

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-11 pm EDT			5-day change	1st Jan Change
2.74 ^USD	+1.86%		+1.48%	+9.60%

Jun. 03	Oncocyte Corporation Announces Promising Results in A Phase 2 Clinical Trial	CI
May. 30	Oncocyte Corporation Announces Favorable Oncocyte Vitgraft Kidney Study Results	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OncoCyte's (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics	Jun. 05	AQ
OncoCyte's Innovative Approach: Potential in Precision Diagnostics	Jun. 05	AQ
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study	Jun. 03	AQ
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine	May. 30	AQ
OncoCyte: Q1 Earnings Snapshot	May. 15	AQ
Oncocyte Reports First Quarter 2024 Financial Results	May. 15	AQ
Oncocyte to Announce First Quarter 2024 Financial Results	May. 13	AQ
PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace	May. 07	AQ
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS	Apr. 15	AQ
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules	Apr. 15	AQ
Oncocyte Reports Full Year 2023 Financial Results	Apr. 12	AQ
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules	Apr. 11	AQ
Oncocyte : and Bio-Rad Partner on Global Launch of Transplant Assay - Form 8-K	Apr. 11	PU
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay	Apr. 11	AQ
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results	Apr. 09	AQ
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico	Jan. 16	AQ
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays	Dec. 06	AQ
OncoCyte: Q3 Earnings Snapshot	Nov. 09	AQ
Oncocyte Reports Third Quarter 2023 Financial Results	Nov. 09	AQ
Oncocyte to Announce Third Quarter 2023 Financial Results	Nov. 03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases OncoCyte Corporation

Equities

OCX

US68235C2061

Press Releases

Filters